Modeling Mitochondrial Metabolism and Related Diseases
Author Information
Author(s): Anthony C. Smith, Alan J. Robinson
Primary Institution: The Medical Research Council, Mitochondrial Biology Unit
Hypothesis
How does mitochondrial metabolic dysfunction contribute to diseases affecting the tricarboxylic acid cycle?
Conclusion
The new metabolic model closely predicts the phenotypes of three metabolic disorders and suggests potential therapeutic interventions.
Supporting Evidence
- The model, called iAS253, includes 253 reactions and 245 metabolites.
- Simulations accurately predicted the effects of three metabolic disorders.
- The model can help investigate other mitochondrial disorders and therapeutic interventions.
Takeaway
Scientists created a model to understand how mitochondria work and how problems in them can cause diseases. This model can help find new treatments.
Methodology
The model was constructed using flux balance analysis and metabolite availability principles, incorporating data from the MitoMiner database.
Limitations
The model may not fully represent all mitochondrial metabolic capabilities due to incomplete data on mitochondrial proteome.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website